Mechanistic description
Imbalanced TREM2/CX3CR1 signaling drives microglial hyperactivation and impaired amyloid clearance. Loss of TREM2 activation combined with elevated CX3CL1-CX3CR1 signaling creates a pro-inflammatory microglial state resistant to transition to disease-associated microglia (DAM), preventing efficient phagocytosis of amyloid plaques while maintaining neurotoxic cytokine release.
Mechanism / pathway
- TREM2, CX3CR1
- neurodegeneration
Evidence for (3)
TREM2 loss-of-function variants increase Alzheimer's disease risk
TREM2-deficient microglia show reduced amyloid phagocytosis in mouse models
CX3CR1 deficiency reduces tau pathology in P301S mice
Evidence against (3)
CX3CR1 deficiency worsens outcomes in stroke and neuroinflammation models
TREM2 activation correlates with disease severity in later stages
APOE4 carriers show increased TREM2 expression in some cohorts
Evidence matrix
Supporting
- TREM2 loss-of-function variants increase Alzheimer's disease risk PMID:24141387
- TREM2-deficient microglia show reduced amyloid phagocytosis in mouse models PMID:25908872
- CX3CR1 deficiency reduces tau pathology in P301S mice PMID:29967354
Contradicting
- CX3CR1 deficiency worsens outcomes in stroke and neuroinflammation models PMID:26729815
- TREM2 activation correlates with disease severity in later stages PMID:31375801
- APOE4 carriers show increased TREM2 expression in some cohorts PMID:30096314
Cite this hypothesis
Cite this hypothesis
envelope-repair (2026). TREM2-CX3CR1 Axis Dysregulation in Microglial Surveillance Failure. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-506d813344
@misc{scidex_hypothesis_h506d813,
title = {TREM2-CX3CR1 Axis Dysregulation in Microglial Surveillance Failure},
author = {envelope-repair},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-506d813344},
note = {SciDEX artifact hypothesis:h-506d813344}
}